Second primary malignancy risk following radioactive iodine therapy for thyroid cancer: a population-based matched cohort study in Taiwan.
- DOI
- 10.1093/ejendo/lvag187
- Published
- 2026 Oct 5
- Container
- European journal of endocrinology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ejendo/lvag187,
title = {Second primary malignancy risk following radioactive iodine therapy for thyroid cancer: a population-based matched cohort study in Taiwan.},
author = {Lin SF and Lu YL and Wu CL and Chang SH and Wong RJ and Huang YT},
year = {2026},
journal = {European journal of endocrinology},
doi = {10.1093/ejendo/lvag187},
url = {https://doi.org/10.1093/ejendo/lvag187}
}RIS
TY - JOUR TI - Second primary malignancy risk following radioactive iodine therapy for thyroid cancer: a population-based matched cohort study in Taiwan. AU - Lin SF AU - Lu YL AU - Wu CL AU - Chang SH AU - Wong RJ AU - Huang YT PY - 2026 JO - European journal of endocrinology DO - 10.1093/ejendo/lvag187 UR - https://doi.org/10.1093/ejendo/lvag187 ER -
APA
SF, L., YL, L., CL, W., SH, C., RJ, W., & YT, H. (2026). Second primary malignancy risk following radioactive iodine therapy for thyroid cancer: a population-based matched cohort study in Taiwan.. European journal of endocrinology. https://doi.org/10.1093/ejendo/lvag187
Source records
- pubmed · retrieved 2026-11-10T16:52:21.388Z
- europe-pmc · retrieved 2026-11-10T16:52:21.385Z